Pretreatment HALP Score and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Tyrosine Kinase Inhibitors: A Turkish Oncology Group Kidney Cancer Consortium (TKCC) Study.

Simple Summary: Prognostic assessment in metastatic renal cell carcinoma may be improved by incorporating simple markers that reflect both tumor-related systemic inflammation and the general condition of the patient. The hemoglobin, albumin, lymphocyte, and platelet (HALP) score combines routinely m...

Descripción completa

Detalles Bibliográficos

Publicado en:	Cancers Vol. 18; no. 13; pp. 2127 - 2141
Autores principales:	Günaltılı, Murat, Bölek, Hatice, Kaplan Tüzün, Esma, Usta, Sura, Efil, Safa Can, Akkus, Aysun Fatma, Işık, Selver, Kapar, Caner, Sekmek, Serhat, Güzel, Halil Göksel, Guliyev, Murad, Ozudogru, Talha, Göksu, Sema Sezin, Sever, Özlem Nuray, Arslan, Çagatay, Karadurmuş, Nuri, Sendur, Mehmet Ali Nahit, Tural, Deniz, Özgüroğlu, Mustafa, Yekedüz, Emre
Formato:	research tables/charts Journal Article
Publicado:	MDPI Jul2026
Acceso en línea:	Ver este registro en EBSCOhost